Micronesia vs Venezuela (Bolivarian Republic of): Proportion of the target population … measles-containing-vaccine
Micronesia
57.0%
in 2024
Venezuela (Bolivarian Republic of)
51.0%
in 2024
Micronesia rank
178th
Venezuela (Bolivarian Republic of) rank
181st
Proportion of the target population … measles-containing-vaccine over time
- Micronesia
- Venezuela (Bolivarian Republic of)
How they compare
Micronesia currently reports 57.0% against 51.0% in Venezuela (Bolivarian Republic of), a difference of 6.0%.
That makes Micronesia's figure about 1.1 times Venezuela (Bolivarian Republic of)'s.
Across all 16 years both countries report, Micronesia has been ahead every year.
Micronesia ranks 178th and Venezuela (Bolivarian Republic of) ranks 181st of 195 countries.
Micronesia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Micronesia | Venezuela (Bolivarian Republic of) | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 62.0% | 6.0% | 56.0% | Micronesia |
| 2010s | 67.6% | 39.4% | 28.2% | Micronesia |
| 2020s | 57.6% | 37.0% | 20.6% | Micronesia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received, Micronesia or Venezuela (Bolivarian Republic of)?
- Micronesia, at 57.0% against 51.0% in Venezuela (Bolivarian Republic of) as of 2024.
- What is the difference in proportion of the target population who received between Micronesia and Venezuela (Bolivarian Republic of)?
- 6.0%, with Micronesia ahead.
- How many years of comparable data are there for Micronesia and Venezuela (Bolivarian Republic of)?
- 16 years are reported by both, from 2009 to 2024.
- How do Micronesia and Venezuela (Bolivarian Republic of) rank globally for proportion of the target population who received?
- Micronesia ranks 178th and Venezuela (Bolivarian Republic of) ranks 181st of 195 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.